Schedule 13G ownership disclosure

EUPRAXIA PHARMACEUTICALS INC

Common Shares, with no par value · CUSIP: 29842P105

Event date: 2025-09-30

Filing-level shares
3,568,150
Percent of class
7%
  • Robert Disbrow

    Shares: 3,568,150 · Class: 7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-25-001321
Form type
SCHEDULE 13G/A
Filer
DISBROW ROBERT
CIK
CIK 1515937
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub